Most cited papers from North Shore Hospital

North Shore Hospital

What are the most cited papers from North Shore Hospital?

The most cited paper from North Shore Hospital is "Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy" (Vlado Perkovic et al., 2019), with 6,216 citations. Next come "Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection" (5,898) and "Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017" (1,734).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 225 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy Vlado Perkovic et al. · New England Journal of Medicine Open access	14 Apr 2019	6,216
2	Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection Bruce C.V. Campbell et al. · New England Journal of Medicine Open access	11 Feb 2015	5,898
3	Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017 Saeid Safiri, Ali‐Asghar Kolahi, Emma U.R. Smith et al. · Annals of the Rheumatic Diseases	12 May 2020	1,734
4	Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia Jan A. Burger et al. · New England Journal of Medicine Open access	6 Dec 2015	1,604
5	Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial Gilles Salles et al. · The Lancet	21 Dec 2010	1,081
6	Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma Philippe Moreau et al. · New England Journal of Medicine Open access	27 Apr 2016	1,067
7	Epidemiology of stroke Ruth Bonita · The Lancet	Feb 1992	993
8	Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance Patrick N. A. Harris et al. · JAMA Open access	11 Sep 2018	791
9	ASAS/EULAR recommendations for the management of ankylosing spondylitis Jane Zochling et al. · Annals of the Rheumatic Diseases Open access	26 Aug 2005	705
10	Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy Bertrand Coiffier, Barbara Pro, Henry Miles Prince et al. · Journal of Clinical Oncology	24 Jan 2012	683
11	Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study Ian W. Flinn, Richard van der Jagt, Brad S. Kahl et al. · Blood Open access	4 Mar 2014	646
12	International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease David C. Fajgenbaum et al. · Blood Open access	13 Jan 2017	641
13	Predictors of persistent pain after total knee arthroplasty: a systematic review and meta-analysis Gwyn Nancy Lewis, David Andrew Rice, Peter John McNair et al. · British Journal of Anaesthesia ReviewOpen access	26 Dec 2014	596
14	Clinical Presentation and Penetrance of Pheochromocytoma/Paraganglioma Syndromes Diana E. Benn et al. · The Journal of Clinical Endocrinology & Metabolism	7 Feb 2006	572
15	Conditioned Pain Modulation in Populations With Chronic Pain: A Systematic Review and Meta-Analysis Gwyn Nancy Lewis, David Andrew Rice, Peter John McNair · Journal of Pain ReviewOpen access	13 Sep 2012	569
16	Effects of Allopurinol on the Progression of Chronic Kidney Disease Sunil V. Badve et al. · New England Journal of Medicine Open access	24 Jun 2020	484
17	Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study Jan A. Burger, Paul M. Barr, Tadeusz Robak et al. · Leukemia Open access	18 Oct 2019	470
18	Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial Frits van Rhee et al. · The Lancet Oncology	17 Jul 2014	454
19	International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease Frits van Rhee et al. · Blood Open access	4 Sep 2018	427
20	The global burden of other musculoskeletal disorders: estimates from the Global Burden of Disease 2010 study Emma U.R. Smith, Damian G Hoy, Marita Cross et al. · Annals of the Rheumatic Diseases	4 Mar 2014	401
21	Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL Constantine Si Lun Tam et al. · Blood Open access	24 Jul 2019	371
22	Clinical practice guidelines for communicating prognosis and end‐of‐life issues with adults in the advanced stages of a life‐limiting illness, and their caregivers Josephine M. Clayton, Karen M. Hancock, Phyllis Noemi Butow et al. · The Medical Journal of Australia Open access	Jun 2007	364
23	A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies S. Couban · Blood	17 May 2002	336
24	Passive smoking as well as active smoking increases the risk of acute stroke Ruth Bonita, James R. Duncan, Thomas Clement Truelsen et al. · Tobacco Control Open access	Jun 1999	334
25	Preoperative physiotherapy for the prevention of respiratory complications after upper abdominal surgery: pragmatic, double blinded, multicentre randomised controlled trial Ianthe J. Boden, Elizabeth H. Skinner, Laura Browning et al. · BMJ Open access	24 Jan 2018	331
26	Clinical Pharmacokinetics of the Salicylates Christopher J. Needs, Peter Brooks · Clinical Pharmacokinetics	1985	324
27	Differences in Craniofacial Structures and Obesity in Caucasian and Chinese Patients with Obstructive Sleep Apnea Richard W. W. Lee, Sivabalan Vasudavan, David S.C. Hui et al. · SLEEP Open access	Aug 2010	322
28	Periprosthetic Joint Infection Is the Main Cause of Failure for Modern Knee Arthroplasty: An Analysis of 11,134 Knees Chuan Kong Koh, Irene S. L. Zeng, Saiprassad Ravi et al. · Clinical Orthopaedics and Related Research Open access	Jun 2017	321
29	First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study Ian W. Flinn, Richard van der Jagt, Brad S. Kahl et al. · Journal of Clinical Oncology Open access	27 Feb 2019	313
30	Delayed versus Immediate Cord Clamping in Preterm Infants William Tarnow‐Mordi et al. · New England Journal of Medicine Open access	29 Oct 2017	313
31	Three steps to changing the narrative about knee osteoarthritis care: a call to action J.P. Cañeiro, Peter O’Sullivan, Ewa Maria Roos et al. · British Journal of Sports Medicine	4 Sep 2019	299
32	Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial Constantine Si Lun Tam et al. · The Lancet Oncology Open access	7 Jul 2022	294
33	Baroreceptor reflex pathways and neurotransmitters: 10 years on Paul M. Pilowsky, Ann K. Goodchild · Journal of Hypertension	Sep 2002	292
34	Differential Changes in Gut Microbiota After Gastric Bypass and Sleeve Gastrectomy Bariatric Surgery Vary According to Diabetes Remission Rinki Murphy, Peter Tsai, Mia Jüllig et al. · Obesity Surgery	13 Oct 2016	291
35	The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group Khalid El Bairi et al. · npj Breast Cancer Open access554 authors	Dec 2021	288
36	Mobile Health (mHealth) in Low- and Middle-Income Countries Judith P. McCool, Rosie Dobson, Robyn Whittaker et al. · Annual Review of Public Health ReviewOpen access	14 Oct 2021	288
37	Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study Emmanuel Bachy et al. · Journal of Clinical Oncology Open access	24 Jul 2019	288
38	A comprehensive survey of wearable and wireless ECG monitoring systems for older adults Mirza Mansoor Baig, Hamid GholamHosseini, Martin Joseph Connolly · Medical & Biological Engineering & Computing	18 Jan 2013	288
39	DOES COLCHICINE WORK? THE RESULTS OF THE FIRST CONTROLLED STUDY IN ACUTE GOUT Michael J Ahern, Carol Reid, Tom P. Gordon et al. · Australian and New Zealand Journal of Medicine	Jun 1987	284
40	Dieulafoy's lesion Yuk Tong Lee, Russell S. Walmsley, Rupert Wing Loong Leong et al. · Gastrointestinal Endoscopy	Aug 2003	276
41	Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial Jeffrey Howard Lipton et al. · The Lancet Oncology	12 Apr 2016	264
42	Effects of Lowering Average or Below-Average Cholesterol Levels on the Progression of Carotid Atherosclerosis Stephen W MacMahon, Norman Sharpe, Greg D. Gamble et al. · Circulation Open access	12 May 1998	263
43	Aspiration during anaesthesia: a review of 133 cases from the Australian Anaesthetic Incident Monitoring Study (AIMS) Michal T. Kluger, Timothy G. Short · Anaesthesia	1999	262
44	Long-term followup of posterior cruciate ligament rupture: A study of 116 cases Mervyn J. Cross, Jacqueline Powell · The American Journal of Sports Medicine	Jul 1984	261
45	Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial María‐Victoria Mateos et al. · The Lancet Haematology Open access121 authors	18 Jul 2019	259
46	The Chitranjan S. Ranawat Award Simon William Young, Matthew Walker, Ali Bayan et al. · Clinical Orthopaedics and Related Research Open access	25 Apr 2016	257
47	Aortic Regurgitation Quantification Using Cardiovascular Magnetic Resonance Saul G. Myerson, Joanna L D’Arcy, Raad Hashem Mohiaddin et al. · Circulation Open access	12 Aug 2012	255
48	Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial Andrew David Zelenetz et al. · The Lancet Oncology Open access	27 Jan 2017	250
49	Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence Emily Stockings, Dino Zagic, Gabrielle Campbell et al. · Journal of Neurology Neurosurgery & Psychiatry ReviewOpen access	6 Mar 2018	247
50	A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting Lisa Pont, Tariq M. Alhawassi, Beata V. Bajorek et al. · Clinical Interventions in Aging ReviewOpen access	Dec 2014	246

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.